Umbilical cord mesenchymal stromal cells (UC-MSCs) are one of the most widely used platforms in regenerative medicine due to their immunomodulatory capability, paracrine signaling potential, and comparative manufacturing advantage over select adult tissue derivatives. In 2026, though, the landscape is no longer shaped so much by broad therapeutic enthusiasm as by concerns about product consistency, […]
Search Diseases & Conditions....

